Ceftobiprole for the treatment of pneumonia

Ceftobiprole is a fifth-generation cephalosporin with potent antimicrobial activity against Gram positive and Gram-negative bacteria. It has been approved in major European countries for the treatment of community-acquired pneumonia (CAP) and hospitalacquired pneumonia (HAP), excluding ventilator-as...

Descripción completa

Detalles Bibliográficos
Autores principales: Cillóniz, Catia, Dominedò, Cristina, Garcia-Vidal, Carolina, Torres, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2019
Materias:
Ceftobiprole Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755349/
https://www.ncbi.nlm.nih.gov/pubmed/31364337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755349/
https://www.ncbi.nlm.nih.gov/pubmed/31364337

Ejemplares similares